

Most Read This Week
- The Effect of Diet on Breast Cancer Recurrence
- Importance of Compassion in Healthcare
- Docetaxel Plus Carboplatin and Trastuzumab in Patients With Metastatic HER2-Positive Breast Cancer: 20-Year Follow-Up
- Efficacy of the Anthracycline-Free Neoadjuvant Regimen of Pembrolizumab and Carboplatin Plus Docetaxel in TNBC
- Overall Survival and Exploratory Biomarker Analyses in Patients With HR+/HER2+ Metastatic Breast Cancer Receiving Abemaciclib Plus Trastuzumab ± Fulvestrant vs Trastuzumab Plus Chemotherapy
Recently Updated
- Mirvetuximab Soravtansine-Gynx Beneficial for FRα-Positive Ovarian Cancer
- SABCS 2023: Abstract Recommendations From Dr. Reshma Mahtani for Breast Cancer
- Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors
- Adverse Events Up With Immune Checkpoint Blockade Added to Periop Cancer Therapy
- Prediction Model for Invasive Breast Cancer Improved With Additional Risk Factors